A Phase II study of Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in the Treatment of Metastatic Colorectal Cancer

AIM: This study was designed to determine the efficacy and tolerability of capecitabine, oxaliplatin and bevacizumab in combination with cetuximab as first-line therapy for advanced colorectal cancer. PATIENTS AND METHODS: Patients with previously untreated advanced colorectal cancer received oxalip...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: WONG, NAN SOON, FERNANDO, NISHAN H., NIXON, ANDREW B., CUSHMAN, STEPHANIE, AKLILU, MEBEA, BENDELL, JOHANNA C., MORSE, MICHAEL A., BLOBE, GERARD C., ASHTON, JILL, PANG, HERBERT, HURWITZ, HERBERT I.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4106457/
https://ncbi.nlm.nih.gov/pubmed/21273607
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky